Although elevation of the liver enzymes alanine transaminase (ALT) and aspartate aminotransferase (AST) in the blood plasma generally provides a first line of evidence (Wong et al., 2018), analysis of a liver biopsy is the gold standard for assessing the presence and severity of NASH. Here, GPT is linked to metabolic dysfunction-associated steatohepatitis.